285 related articles for article (PubMed ID: 11099686)
1. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.
Ishani A; MacDonald R; Nelson D; Rutks I; Wilt TJ
Am J Med; 2000 Dec; 109(8):654-64. PubMed ID: 11099686
[TBL] [Abstract][Full Text] [Related]
2. Pygeum africanum for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
[TBL] [Abstract][Full Text] [Related]
3. Phytotherapy for benign prostatic hyperplasia.
Wilt TJ; Ishani A; Rutks I; MacDonald R
Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
[TBL] [Abstract][Full Text] [Related]
4. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.
Wilt TJ; Ishani A; Stark G; MacDonald R; Lau J; Mulrow C
JAMA; 1998 Nov; 280(18):1604-9. PubMed ID: 9820264
[TBL] [Abstract][Full Text] [Related]
5. Cernilton for benign prostatic hyperplasia.
Wilt T; Mac Donald R; Ishani A; Rutks I; Stark G
Cochrane Database Syst Rev; 2000; (2):CD001042. PubMed ID: 10796739
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study].
Barlet A; Albrecht J; Aubert A; Fischer M; Grof F; Grothuesmann HG; Masson JC; Mazeman E; Mermon R; Reichelt H
Wien Klin Wochenschr; 1990 Nov; 102(22):667-73. PubMed ID: 1702916
[TBL] [Abstract][Full Text] [Related]
7. WITHDRAWN: Cernilton for benign prostatic hyperplasia.
Wilt TJ; Macdonald R; Ishani A; Rutks I; Stark G
Cochrane Database Syst Rev; 2011 May; 2011(5):CD001042. PubMed ID: 21563128
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia.
MacDonald R; Ishani A; Rutks I; Wilt TJ
BJU Int; 2000 May; 85(7):836-41. PubMed ID: 10792162
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.
Breza J; Dzurny O; Borowka A; Hanus T; Petrik R; Blane G; Chadha-Boreham H
Curr Med Res Opin; 1998; 14(3):127-39. PubMed ID: 9787978
[TBL] [Abstract][Full Text] [Related]
10. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R
Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
[TBL] [Abstract][Full Text] [Related]
11. Serenoa repens for benign prostatic hyperplasia.
Tacklind J; Macdonald R; Rutks I; Stanke JU; Wilt TJ
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD001423. PubMed ID: 23235581
[TBL] [Abstract][Full Text] [Related]
12. Serenoa repens for benign prostatic hyperplasia.
Tacklind J; MacDonald R; Rutks I; Wilt TJ
Cochrane Database Syst Rev; 2009 Apr; (2):CD001423. PubMed ID: 19370565
[TBL] [Abstract][Full Text] [Related]
13. beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review.
Wilt TJ; MacDonald R; Ishani A
BJU Int; 1999 Jun; 83(9):976-83. PubMed ID: 10368239
[TBL] [Abstract][Full Text] [Related]
14. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Stark G; MacDonald R; Mulrow C; Lau J
Cochrane Database Syst Rev; 2000; (2):CD001423. PubMed ID: 10796790
[TBL] [Abstract][Full Text] [Related]
15. [Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma].
Dufour B; Choquenet C; Revol M; Faure G; Jorest R
Ann Urol (Paris); 1984 May; 18(3):193-5. PubMed ID: 6084978
[TBL] [Abstract][Full Text] [Related]
16. Tamsulosin for benign prostatic hyperplasia.
Wilt TJ; Mac Donald R; Rutks I
Cochrane Database Syst Rev; 2003; (1):CD002081. PubMed ID: 12535426
[TBL] [Abstract][Full Text] [Related]
17. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens.
Levin RM; Das AK
Urol Res; 2000 Jun; 28(3):201-9. PubMed ID: 10929430
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia.
Boyle P; Robertson C; Lowe F; Roehrborn C
Urology; 2000 Apr; 55(4):533-9. PubMed ID: 10736497
[TBL] [Abstract][Full Text] [Related]
19. Beta-sitosterols for benign prostatic hyperplasia.
Wilt T; Ishani A; MacDonald R; Stark G; Mulrow C; Lau J
Cochrane Database Syst Rev; 2000; 1999(2):CD001043. PubMed ID: 10796740
[TBL] [Abstract][Full Text] [Related]
20. Terazosin for benign prostatic hyperplasia.
Wilt TJ; Howe RW; Rutks IR; MacDonald R
Cochrane Database Syst Rev; 2002; (4):CD003851. PubMed ID: 12519611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]